Table 4.

Characteristics of VIA/Pap/HR-HPV testing for post-treatment follow-up for detection of CIN2+.^a

	Sensitivity	Specificity	Correctly Classified	PPV	NPV
VIA	0.27 (0.18, 0.36)	0.82 (0.79, 0.86)	0.72 (0.68, 0.77)	0.25 (0.17, 0.33)	0.84 (0.80, 0.88)
PAP	0.44 (0.35, 0.53)	0.91 (0.88, 0.95)	0.83 (0.79, 0.87)	0.52 (0.42, 0.62)	0.88 (0.84, 0.92)
HR HPV	0.85 (0.75, 0.96)	0.54 (0.49, 0.58)	0.59 (0.55, 0.64)	0.29 (0.23, 0.34)	0.94 (0.90, 0.99)
VIA & PAP	0.13 (0.08, 0.17)	0.97 (0.95, 0.99)	0.82 (0.78, 0.86)	0.50 (0.32, 0.68)	0.84 (0.80, 0.87)
VIA & HR HPV	0.22 (0.15, 0.29)	0.89 (0.86, 0.93)	0.77 (0.74, 0.81)	0.31 (0.21, 0.41)	0.84 (0.80, 0.88)
PAP & HR HPV	0.31 (0.24, 0.38)	0.94 (0.92, 0.97)	0.83 (0.79, 0.86)	0.54 (0.44, 0.65)	0.86 (0.83, 0.90)
VIA & PAP & HR HPV	0.09 (0.05, 0.13)	0.98 (0.96, 0.99)	0.82 (0.78, 0.86)	0.45 (0.26, 0.65)	0.83 (0.79, 0.87)
VIA | PAP	0.59 (0.48, 0.69)	0.76 (0.72, 0.81)	0.73 (0.69, 0.77)	0.35 (0.28, 0.41)	0.89 (0.85, 0.94)
VIA | HR HPV	0.90 (0.80, 1.00)	0.47 (0.42, 0.51)	0.54 (0.50, 0.59)	0.27 (0.22, 0.32)	0.96 (0.90, 1.00)
PAP | HR HPV	0.99 (0.89, 1.00)	0.51 (0.46, 0.55)	0.59 (0.55, 0.64)	0.30 (0.25, 0.35)	0.99 (0.95, 1.00)
VIA | PAP | HR HPV	1.00 (0.91, 1.00)	0.44 (0.39, 0.48)	0.54 (0.49, 0.58)	0.28 (0.23, 0.32)	1.00 (1.00, 1.00)

^aAnalysis assumed triple negatives are truly negatives and imputed those with otherwise missing histology